Press Releases from Marinomed Biotechnologie GmbH (4 total)
Viennese biotech company Marinomed demonstrates the benefits of its patented Mar …
• Solubilization of the immunomodulator tacrolimus up to 200 times greater using Marinosolv®
• Bioavailability in the eye up to 15 times higher under laboratory conditions…
Marinomed Biotechnologie GmbH: New investment boosts global expansion / innovati …
Marinomed Biotechnologie GmbH will boost the successful expansion of its business activities with new investments. The Austrian investment fund "aws Mittelstandsfonds" is acquiring a share…
Marinomed Biotechnologie GmbH: French Nicox S.A. successfully bids for anti-vira …
Vienna – Marinomed Biotechnologie GmbH agreed to sell its promising anti-viral eye drop program to Nicox S.A. of France. The France-based international ophthalmic company acquires…
Marinomed Biotechnologie GmbH: Pharma Company Acquires Rights to Antiviral Produ …
MAVIREX® technology is the basis for five products against viral respiratory infections
The rights to five medical products of the Viennese biotech company Marinomed have…
Go To Page:
